Search
for
Sort by
Research 91–120 of 1000+
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Chemotherapy and the Skin: Understanding Dermatologic Side Effects
- Updates in the understanding and treatments of skin & hair disorders in women of color
- Targeted Treatments of Non-Small Cell Lung Cancer (NSCLC): Skin Toxicity
- The role of protein lactylation in skin diseases: from molecular mechanisms to potential therapeutics
- <i>Malassezia</i> and the Asian menopausal skin
- Severe skin toxicity during whole-brain radiotherapy, targeted therapy, and additional drug intake including St. John’s wort skin oil
- Small Molecule Inhibitors and Inflammatory Skin Diseases
- Air pollution and skin diseases: Adverse effects of airborne particulate matter on various skin diseases
- Sanhuang Fukang oil alleviates X-ray-induced skin injury by reducing inflammation and apoptosis: an in vivo study
- Dermoscopy — 4th Conference of the Section of Dermoscopy and Other Skin Imaging Techniques (DiTOS) of the Polish Dermatological Society — Abstracts
- Exploring the Role of Tripeptides in Wound Healing and Skin Regeneration: A Comprehensive Review
- Guidelines of care for superficial mycotic infectionsof the skin: Tinea capitis and tinea barbae
- Cortexolone 17a-propionate: Preclinical profile of a new topical, skin selective, steroidal antiandrogen
- Xenobiotica-metabolizing enzymes in the skin of rat, mouse, pig, guinea pig, man, and in human skin models
- Risk of Autoimmune Skin Diseases Associated With Immune Checkpoint Inhibitors: A Pharmacovigilance Analysis Using the FAERS Database
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- Contribution of the Hair Follicular Pathway to Total Skin Permeation of Topically Applied and Exposed Chemicals
- Related Topic: Drug Permeation Through Hair Follicles
- RASopathic Skin Eruptions during Vemurafenib Therapy
- Topical use of systemic drugs in dermatology: A comprehensive review
- A Case of Cicatricial Alopecia Associated with Erlotinib
- Dermatologic Reactions to Targeted Therapy
- Nodular-cystic eruption in course of sorafenib administration for hepatocarcinoma: An unconventional skin reaction requiring unconventional treatment
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- Cultured Human Foreskin as a Model System for Evaluating Ionizing Radiation-Induced Skin Injury
- Cutaneous Side Effects of Chemotherapy and Radiotherapy
- Ruxolitinib protects skin stem cells and maintains skin homeostasis in murine graft-versus-host disease
- Is dehydroepiandrosterone a hormone?
- Mucocutaneous reactions to chemotherapy